Loading...

PHARMACY AND PHARMACOLOGY JOURNAL

Mohammed El-Gamal

Biography:

Dr. Mohammed I. El-Gamal has an illustrious academic background, having earned his B.Sc. degree in pharmaceutical Sciences from the Faculty of Pharmacy at the University of Mansoura, Egypt, in 2003, where he graduated with "Excellent with honor" grade, being the first achiever. He continued his academic journey by obtaining his M.Sc. degree in medicinal chemistry from the same institution.

In pursuit of further academic and research excellence, Dr. El-Gamal ventured to Korea University of Science and Technology, Korea Institute of Science and Technology (KIST), Republic of Korea, where he earned his Ph.D. degree in medicinal chemistry in August 2012. Following the completion of his doctoral studies, he embarked on a successful career path that led him to significant achievements in academia and research.

Dr. El-Gamal's expertise lies in the field of medicinal chemistry, where he has made notable contributions. During his tenure as a star postdoctoral fellow at KIST and as an assistant professor of medicinal chemistry at the Faculty of Pharmacy, University of Mansoura, Egypt, he has demonstrated a remarkable ability to innovate and advance the field.

One of Dr. El-Gamal's notable achievements is the development of a new, more efficient prodrug of Olmesartan, an antihypertensive agent. This innovative prodrug, which he and his group developed, has been successfully marketed in the Republic of Korea, underscoring the practical implications of his research in improving healthcare outcomes.

Overall, Dr. Mohammed I. El-Gamal's academic journey and research accomplishments highlight his dedication to advancing the field of medicinal chemistry and his commitment to improving pharmaceutical therapies for the benefit of patients worldwide.

Research Interests:

Anticancer agents, Anti-inflammatory agents, Antihypertensive Agents, Antimicrobial agents, Drug Design and Synthesis, Pharmacodynamics, Pharmacokinetics.

Open Access Journals

Recently Released Issues

Social Network

Loading ....
Loading ....
Loading ....

Abstracting and Indexing

Boffin Access use Crossref Similarity Check for averting plagiarism

Retractions

Boffin Access Limited is committed to maintaining the integrity of the scholarly record to researchers. Therefore violation of professional ethical codes may lead to retract articles. Article(s) may be retracted if it is found to have serious flaws, reported misconduct research, constitute copyright infringement and plagiarism.
To help avoid the incorrect or misleading publications, please drop your message to

Send Information

Subscribe to our Newsletter

Enter your e-mail address to stay informed about published articles, issue releases and latest updates on journal activities.

Feedback

We openly welcome feedback and constructive criticism. Your compliments, concerns and suggestions regarding our services will prove enormously helpful in making them even better.

Do you have an idea or suggestion that can influence the Open Access community? Send an email to: support@boffinaccess.org